Cat. No. | Product name | CAS No. |
DCC4682 |
Se-nsaid-8
Novel selenium-nonsteroidal anti-inflammatory drug (Se-NSAID), inhibiting colorectal cancer (CRC) growth via the inhibition of the cell cycle in G1 and G2/M phases and reduces the cell cycle markers like cyclin E1 and B1 in a dose dependent manner |
|
DCC4683 |
Sephin1 Hydrochloride
Selective inhibitor of the phosphatase regulatory subunit PPP1R15A (R15A) that prolong the benefit of eIF2α phosphorylation, thereby protecting cells from proteostatic defects |
32597-86-7 |
DCC4684 |
Ser@tpp@cur
Novel mitochondrial KIM-1 receptor modulator to be specifically internalized by renal tubular epithelial cells via KIM-1 receptor-mediated endocytosis and then actively distributed in mitochondria under the effect of TPP, effectively ameliorating injured |
|
DCC4685 |
Sert Inhibitor 69419
Novel serotonin reuptake inhibitor |
305374-42-9 |
DCC4686 |
Sertaconazole
Cytochrome P450 14α-demethylase inhibitor, also acting as a BuChE-IDO1 inhibitor |
99592-32-2 |
DCC4687 |
Setastine
Highly selective H1 receptor antagonist |
64294-95-7 |
DCC4688 |
Sethrrs Inhibitor 36j
The first-in-class triple-site aaRS inhibitor, targeting Salmonella enterica threonyl-tRNA synthetase (SeThrRS) with IC 50 = 19 nM and K d = 35.4 nM |
|
DCC4689 |
Setin-1
The most potent inhibitor of Set7, inhibiting the KMTase G9a |
1313802-67-3 |
DCC4690 |
Trichomonacid
Novel inhibitor of Mycobacterium marinum MelF (Rv1936), exhibiting bacteriostatic/bactericidal activity against M. marinum and M. tuberculosis in vitro |
7195-14-4 |
DCC4691 |
Seviteronel
Novel potent CYP17 lyase inhibitor, inhibiting androgen production without mineralocorticoid excess or cortisol depletion |
1610537-15-9 |
DCC4692 |
sew05920
Novel telomerase inhibitor |
260392-16-3 |
DCC4693 |
Sew-05929
The First potent SecA inhibitor |
260392-25-4 |
DCC4694 |
Sf-1-087
Potent and selective STAT5 inhibitor |
|
DCC4695 |
Sf-22 (npy Y2 Antagonist)
Potent, selective, and highly brain-penetrant NPY Y2 receptor antagonist |
824981-55-7 |
DCC4696 |
Sf2535
Novel dual inhibitor of BRD4 and PI3K, inhibiting BRD4, PI3Kα, PI3Kδ, and PI3Kγ with IC 50 values of 277, 714, 27, and 1170 nM, respectively |
|
DCC4697 |
Sfom-0046
Novel anticancer agent, arresting cell cycle in S-phase and causes DNA replication stress leading to the phosphorylation of H2AX into gamma-H2AX |
1383607-61-1 |
DCC4698 |
Sfrp-1 Inhibitor-1
Cell-permeable antagonist of secreted frizzled related protein-1(sFRP-1), inhibiting Wnt-3/frizzled interaction and restoring cellular response to Wnt-3 stimulation |
302804-57-5 |
DCC4699 |
Sfti-1
Highly Potent and Selective Plasmin Inhibitor, Attenuating Fibrinolysis in Plasma |
|
DCC4700 |
Sgc-camkk2-1
Novel probe for CAMKK2/CAMKK1 |
|
DCC4701 |
Sgc-clk-1
Novel probe for CLK1, CLK2, and CLK4 |
|
DCC4702 |
Sgc-gak-1n
Negative control for SGC-GAK-1 (GLXC-31266) |
|
DCC4703 |
Sge201
Novel potent allosteric modulator of N-methyl-D-aspartate receptors (NMDAR) |
35882-85-0 |